Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera

R Rathnasinghe, S Jangra, C Ye, A Cupic… - Nature …, 2022 - nature.com
Due to differences in human and murine angiotensin converting enzyme 2 (ACE-2) receptor,
initially available SARS-CoV-2 isolates could not infect mice. Here we show that serial …

Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein

P Wang, SY Lau, S Deng, P Chen, BWY Mok… - Nature …, 2021 - nature.com
SARS-CoV-2 is of zoonotic origin and contains a PRRA polybasic cleavage motif which is
considered critical for efficient infection and transmission in humans. We previously reported …

Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection

K Li, A Verma, P Li, ME Ortiz, GM Hawkins… - Journal of …, 2024 - Am Soc Microbiol
ABSTRACT The Coronavirus Disease 2019 (COVID-19) pandemic continues to cause
extraordinary loss of life and economic damage. Animal models of severe acute respiratory …

[HTML][HTML] Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

EC Chen, P Gilchuk, SJ Zost, N Suryadevara… - Cell Reports, 2021 - cell.com
Unrelated individuals can produce genetically similar clones of antibodies, known as public
clonotypes, which have been seen in responses to different infectious diseases, as well as …

SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunity

M Sasaki, S Toba, Y Itakura, HM Chambaro… - Mbio, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) possesses a
discriminative polybasic cleavage motif in its spike protein that is recognized by the host …

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Z Liu, LA VanBlargan, LM Bloyet, PW Rothlauf… - Cell host & …, 2021 - cell.com
Neutralizing antibodies against the SARS-CoV-2 spike (S) protein are a goal of COVID-19
vaccines and have received emergency use authorization as therapeutics. However, viral …

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2

D Kim, J Kim, M Kim, H Park, S Park… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction The spectrum of SARS-CoV-2 mutations have increased over time, resulting in
the emergence of several variants of concern. Persistent infection is assumed to be involved …

High-titer neutralization of Mu and C. 1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals

T Tada, H Zhou, BM Dcosta, MI Samanovic… - Cell Reports, 2022 - cell.com
Recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
Mu and C. 1.2 have spike proteins with mutations that may confer resistance to natural and …

Emerging SARS-CoV-2 variants expand species tropism to murines

H Shuai, JFW Chan, TTT Yuen, C Yoon, JC Hu… - …, 2021 - thelancet.com
Background Wildtype mice are not susceptible to SARS-CoV-2 infection. Emerging SARS-
CoV-2 variants, including B. 1.1. 7, B. 1.351, P. 1, and P. 3, contain mutations in spike that …

The great escape? SARS-CoV-2 variants evading neutralizing responses

J Prévost, A Finzi - Cell Host & Microbe, 2021 - cell.com
In the latest issues of Cell Host & Microbe and Cell, three articles describe new mutations in
the SARS-CoV-2 Spike receptor binding domain that escape neutralizing responses. These …